Opus Genetics

Raleigh’s Opus Genetics, with $19M in funding, hires two executives

Posted by Jason Parker | Oct 20, 2021

Opus Genetics launched in September, with $19 million in funding. Now, the company is adding to its leadership team, adding a chief scientific officer and a chief operating officer.

Read More

Opus Genetics, launching from Raleigh-based Retinal Degeneration Fund, raises $19M

Posted by Jason Parker | Sep 22, 2021

With $19 million in seed funding, newly formed Raleigh company Opus Genetics seeks to develop gene therapies to enable vision for patients who inherited blindness.

Read More

1
2